This platform is exclusively for licensed businesses, trade buyers, and qualified professionals operating in regulated cannabis markets. It is not intended for consumers or the general public.
By entering you confirm compliance with applicable laws in your jurisdiction.
Cannvera EU · B2B only · Not for consumer use.
Cannvera is a global cannabis sourcing and supply partner — connecting buyers in pharmaceutical, wellness, and regulated markets with verified, documented product from the world's best-producing regions.

Cannvera was founded in 2022 to solve a problem that every serious cannabis buyer knows well: the gap between what's available globally and what's actually accessible — with the right documentation, the right certifications, and the right people behind it.
We source from the world's leading cannabis-producing regions — Canada, Israel, the United States, Thailand, Australia, and across Europe — and process through four EU GMP-certified manufacturing partners (facility names and certificates provided on request under NDA), all with active supply track records across the European market. The result is a product portfolio that spans pharmaceutical-grade flower and extracts through to premium indoor genetics, concentrates, and isolates.
Our buyers include licensed importers, pharmacy procurement teams, wellness brands, adult-use market operators, and product manufacturers across Germany, Austria, Switzerland, Poland, the Czech Republic, the United Kingdom, South Africa, Australia, and Israel. We've supplied pharmaceutical, wellness, and adult-use channels — and we understand the documentation requirements, the regulatory nuances, and the commercial realities of each.
Cannvera's wider team brings over three decades of combined experience in cultivation, manufacturing, breeding, international cannabis logistics, narcotics compliance, and cross-border trade. We work with a small number of buyers at any given time, which means every relationship gets the attention it deserves.

Eshel has spent over a decade in the global cannabis industry — building supply chains for pharmaceutical markets and developing premium brands for wellness and regulated market buyers. Having VP'd Tikun Olam Cannbit, Israel's first and oldest licensed medical cannabis producer. Cannvera's wider team brings over three decades of combined experience in international cannabis logistics, narcotics compliance, and cross-border trade.
His experience spans both sides of the market: pharmaceutical-grade GMP supply for licensed importers and pharmacy procurement teams, and premium brand development for wellness and adult-use markets. He has been involved in multi-7 and 8-figure transactions across the industry, including company sales and cross-border supply agreements at scale.
Cannvera is built on that multi-channel expertise — a platform that can serve a German pharmacy procurement manager, a Czech adult-use buyer, and a South African wellness brand with equal rigour, equal documentation, and equal care.
Material sourced from the world's leading cannabis-producing regions — Canada, Israel, the US, Thailand, Australia, and across Europe. Best genetics, best price, best documentation.
Processed through four EU GMP-certified facilities, all with active EU market supply track records spanning the last five years. Facility names and certificates provided on request under NDA.
COA library, cannabinoid profiles, contaminant screening, GACP cultivation records, and country-specific import documentation prepared for every shipment.
Direct to licensed importers and buyers across Germany, Austria, Switzerland, Poland, Czech Republic, UK, South Africa, Australia, and Israel.

Direct contact with the Cannvera team.